Bet v 1 recombinant allergen

recombinant Bet v 1 allergen · Allergopharma GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bet v 1 recombinant allergen, covering 2013-11-08 to 2013-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 [Phase 3]